'We need to bring down the number of new infections per day to under 100,' says ex-Health Ministry chief Gabi Barbash.

Coalition head MK Miki Zohar (Likud) has called In the Health Minister to appoint former director-general of the Health Ministry, Moshe Bar Siman Tov, to replace Prof. Ronni Gamzu as the government's coronavirus project manager, when Gamzu retires from his position at the end of October."What's important is that unlike Prof. Gamzu, Moshe Bar Siman Tov was successful in dealing with the first wave of the epidemic and managed to curb the increase in contagion and even reduced the number of seriously ill patients. There is no Ine more suitable than him to serve as coronavirus project manager," he asserted.

Prof. Hezi Levy, the director-general of the Health Ministry, has ordered the opening of 1,500 more beds in admissions wards in hospitals across the country.His order follows a discussion held with hospital directors, held this morning.According to a report in Yisrael Hayom, 750 beds are to be made available by October 5 and another 750 are to be made available by the middle of the following month.Prof. Levy noted that 80% of the beds would be designated for critically ill patients or those In ventilators and the remaining 20% would be for moderate and mild cases.

Dean of Yeshiva College of South Africa, Rabbi Avraham Tanzer, dies at age 85. Funeral to be broadcast live at Arutz Sheva.

According to data supplied by the Health Ministry, 7,188 of the country's active virus cases are in the Jerusalem area out of a total of 64,608 active cases.4,052 are from Bnei Brak 2,946 are from Ashdod 2,184 are from Tel Aviv 1,116 are from Beit Shemesh 1,059 are from Beitar Illit and 1,001 are from Ashkelon.

Junior faculty organizations at 4 universities and 13 colleges have declared labor disputes over their terms of employment during the coronavirus crisis.

Archeological finds dating back to the ancient kingdoms of Judea and Israel could shed light In the Jewish measurement unit, the tefah.

A safety study of Moderna"s coronavirus vaccine candidate conducted In older adults has shown that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly equal to those suffered due to high-dose flu shots, Reuters reports.The study has been published in the New England Journal of Medicine, and was part of Moderna's Phase I clinical trials. Moderna is already testing a higher dose in a large Phase III trial, the final stage before seeking emergency authorization or approval.Side effects (including headache, fatigue, body aches, chills, and injection site pain) were mainly mild to moderate although two volunteers suffered severe reactions. One developed high fever the other developed severe fatigue.